カテゴリー： Bizwit Research & Consulting, 世界, 医療/バイオ

世界の骨髄異形成症候群（MDS）治療市場2022年-2028年：治療種類別（化学療法、免疫治療、幹細胞移植、その他）、エンドユーザー別、地域別

【英語タイトル】Global Myelodysplastic Syndrome (MDS) Treatment Market Size study, by Treatment Type (Chemotherapy, Immune Treatments,　Stem Cell Transplant, Other Treatment Types), by End-User (Hospitals, Specialty Clinics, Other End-Users) and Regional Forecasts 2022-2028

Bizwit Research & Consultingが出版した調査資料（BZW22JY097）・商品コード：BZW22JY097
・発行会社（調査会社）：Bizwit Research & Consulting
・発行日：2022年6月7日
・ページ数：約200
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用、印刷不可）USD4,950 ⇒換算￥643,500見積依頼/購入/質問フォーム
Enterprisewide（同一法人内共有可）USD6,250 ⇒換算￥812,500見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
Bizwit Research社は、2021年におよそXXXX億ドルであった世界の骨髄異形成症候群（MDS）治療市場規模が、2022年から2028年の間にXX％以上成長すると予測しています。本調査レポートは、骨髄異形成症候群（MDS）治療の世界市場を調査対象とし、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、治療種類別（化学療法、免疫治療、幹細胞移植、その他）分析、エンドユーザー別（病院、専門クリニック、その他）分析、地域別分析、競争分析、調査プロセスなどの内容をまとめております。本レポートには、AbbVie Inc.、Accord Healthcare、Bristol-Myers Squibb、Jazz Pharmaceuticals Inc、Novartis AG、Lupin Pharmaceuticals、Otsuka America Pharmaceutical Inc.、Onconova Therapeutics、Takeda Pharmaceutical Company Limited、Astex Pharmaceuticals, Inc.などの企業情報が含まれております。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界の骨髄異形成症候群（MDS）治療市場規模：治療種類別（化学療法、免疫治療、幹細胞移植、その他）
・世界の骨髄異形成症候群（MDS）治療市場規模：エンドユーザー別（病院、専門クリニック、その他）
・世界の骨髄異形成症候群（MDS）治療市場規模：地域別
・競争分析
・調査プロセス
❖ レポートの概要 ❖

Global Myelodysplastic Syndrome (MDS) Treatment Market is valued at approximately USD XXXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Myelodysplastic Syndrome (MDS) Treatment is a term used to describe a category of bone marrow disorders in which the bone marrow fails to create enough healthy blood cells. MDS is also known as “bone marrow failure condition”. Ineffective hematopoiesis, as well as anomalies in proliferation, differentiation, and apoptosis, characterise these illnesses. The increased R&D spending on new drug development and increasing public awareness have led to the adoption of Myelodysplastic Syndrome (MDS) Treatment across the forecast period. For Instance: as per Cancer.Net in 2022, every year, about 10,000 people in the United States are diagnosed with MDS. MDS is rare in adults under the age of 50. People in their 70s are the most likely to develop it. The number of people diagnosed with MDS each year is projected to rise as the US population continues to age. As per Congressional Budget Office 2021, the pharmaceutical sector spent $83 billion on research and development in 2019. Inflation-adjusted, that sum is around ten times what the industry spent every year in the 1980s. Also, some initiatives by the government to provide targeted therapies and attractive reimbursement policies are likely to increase the market growth during the forecast period. However, adverse effects caused by the medicine may impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global Myelodysplastic Syndrome (MDS) Treatment market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to increased R&D spending on new drug development and increasing public awareness. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as initiatives by the government to provide targeted therapies and attractive reimbursement policies would create lucrative growth prospects for the Myelodysplastic Syndrome (MDS) Treatment market across Asia-Pacific region.

Major market players included in this report are:
AbbVie Inc.
Accord Healthcare
Bristol-Myers Squibb
Jazz Pharmaceuticals Inc
Novartis AG
Lupin Pharmaceuticals
Otsuka America Pharmaceutical Inc.
Onconova Therapeutics
Takeda Pharmaceutical Company Limited
Astex Pharmaceuticals, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment:
Chemotherapy,
Immune Treatments
Stem Cell Transplant
Other Treatment Types

By End-User:
Hospitals
Specialty Clinics
Other End-Users

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Myelodysplastic Syndrome (MDS) Treatment Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

❖ レポートの目次 ❖

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Myelodysplastic Syndrome (MDS) Treatment Market, by Region, 2020-2028 (USD Billion)
1.2.2. Myelodysplastic Syndrome (MDS) Treatment Market, by Treatment Type, 2020-2028 (USD Billion)
1.2.3. Myelodysplastic Syndrome (MDS) Treatment Market, by End-User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Myelodysplastic Syndrome (MDS) Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Myelodysplastic Syndrome (MDS) Treatment Market Dynamics
3.1. Myelodysplastic Syndrome (MDS) Treatment Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increased R&D spending on new drug development
3.1.1.2. Increasing public awareness
3.1.2. Market Challenges
3.1.2.1. Adverse effects caused by the medicine
3.1.3. Market Opportunities
3.1.3.1. Initiatives by the government to provide targeted therapies and attractive reimbursement policies
Chapter 4. Global Myelodysplastic Syndrome (MDS) Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Myelodysplastic Syndrome (MDS) Treatment Market, by Treatment Type
6.1. Market Snapshot
6.2. Global Myelodysplastic Syndrome (MDS) Treatment Market by Treatment Type, Performance – Potential Analysis
6.3. Global Myelodysplastic Syndrome (MDS) Treatment Market Estimates & Forecasts by Treatment Type, 2018-2028 (USD Billion)
6.4. Myelodysplastic Syndrome (MDS) Treatment Market, Sub Segment Analysis
6.4.1. Chemotherapy
6.4.2. Immune Treatments
6.4.3. Stem Cell Transplant
6.4.4. Other Treatment Types
Chapter 7. Global Myelodysplastic Syndrome (MDS) Treatment Market, by End-User
7.1. Market Snapshot
7.2. Global Myelodysplastic Syndrome (MDS) Treatment Market by End-User, Performance – Potential Analysis
7.3. Global Myelodysplastic Syndrome (MDS) Treatment Market Estimates & Forecasts by End-User, 2018-2028 (USD Billion)
7.4. Myelodysplastic Syndrome (MDS) Treatment Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Specialty Clinics
7.4.3. Other End-Users
Chapter 8. Global Myelodysplastic Syndrome (MDS) Treatment Market, Regional Analysis
8.1. Myelodysplastic Syndrome (MDS) Treatment Market, Regional Market Snapshot
8.2. North America Myelodysplastic Syndrome (MDS) Treatment Market
8.2.1. U.S. Myelodysplastic Syndrome (MDS) Treatment Market
8.2.1.1. Treatment Type breakdown estimates & forecasts, 2018-2028
8.2.1.2. End-User breakdown estimates & forecasts, 2018-2028
8.2.2. Canada Myelodysplastic Syndrome (MDS) Treatment Market
8.3. Europe Myelodysplastic Syndrome (MDS) Treatment Market Snapshot
8.3.1. U.K. Myelodysplastic Syndrome (MDS) Treatment Market
8.3.2. Germany Myelodysplastic Syndrome (MDS) Treatment Market
8.3.3. France Myelodysplastic Syndrome (MDS) Treatment Market
8.3.4. Spain Myelodysplastic Syndrome (MDS) Treatment Market
8.3.5. Italy Myelodysplastic Syndrome (MDS) Treatment Market
8.3.6. Rest of Europe Myelodysplastic Syndrome (MDS) Treatment Market
8.4. Asia-Pacific Myelodysplastic Syndrome (MDS) Treatment Market Snapshot
8.4.1. China Myelodysplastic Syndrome (MDS) Treatment Market
8.4.2. India Myelodysplastic Syndrome (MDS) Treatment Market
8.4.3. Japan Myelodysplastic Syndrome (MDS) Treatment Market
8.4.4. Australia Myelodysplastic Syndrome (MDS) Treatment Market
8.4.5. South Korea Myelodysplastic Syndrome (MDS) Treatment Market
8.4.6. Rest of Asia Pacific Myelodysplastic Syndrome (MDS) Treatment Market
8.5. Latin America Myelodysplastic Syndrome (MDS) Treatment Market Snapshot
8.5.1. Brazil Myelodysplastic Syndrome (MDS) Treatment Market
8.5.2. Mexico Myelodysplastic Syndrome (MDS) Treatment Market
8.6. Rest of The World Myelodysplastic Syndrome (MDS) Treatment Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. AbbVie Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Accord Healthcare
9.2.3. Bristol-Myers Squibb
9.2.4. Jazz Pharmaceuticals Inc
9.2.5. Novartis AG
9.2.6. Lupin Pharmaceuticals
9.2.7. Otsuka America Pharmaceutical Inc.
9.2.8. Onconova Therapeutics
9.2.9. Takeda Pharmaceutical Company Limited
9.2.10. Astex Pharmaceuticals, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

List of Tables
TABLE 1. Global Myelodysplastic Syndrome (MDS) Treatment Market, report scope
TABLE 2. Global Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by Treatment Type 2018-2028 (USD Billion)
TABLE 4. Global Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by End-User 2018-2028 (USD Billion)
TABLE 5. Global Myelodysplastic Syndrome (MDS) Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 6. Global Myelodysplastic Syndrome (MDS) Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 7. Global Myelodysplastic Syndrome (MDS) Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Myelodysplastic Syndrome (MDS) Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Myelodysplastic Syndrome (MDS) Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Myelodysplastic Syndrome (MDS) Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Myelodysplastic Syndrome (MDS) Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Myelodysplastic Syndrome (MDS) Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Myelodysplastic Syndrome (MDS) Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Myelodysplastic Syndrome (MDS) Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. U.S. Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. U.S. Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 17. U.S. Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 18. Canada Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 19. Canada Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 20. Canada Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 21. UK Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 22. UK Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 23. UK Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 24. Germany Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 25. Germany Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 26. Germany Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 27. RoE Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 28. RoE Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 29. RoE Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 30. China Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 31. China Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 32. China Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 33. India Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 34. India Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 35. India Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 36. Japan Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 37. Japan Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 38. Japan Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 39. RoAPAC Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 40. RoAPAC Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 41. RoAPAC Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 42. Brazil Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 43. Brazil Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 44. Brazil Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 45. Mexico Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 46. Mexico Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 47. Mexico Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 48. RoLA Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 49. RoLA Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 50. RoLA Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 51. Row Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 52. Row Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 53. Row Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 54. List of secondary sources, used in the study of Global Myelodysplastic Syndrome (MDS) Treatment Market
TABLE 55. List of primary sources, used in the study of Global Myelodysplastic Syndrome (MDS) Treatment Market
TABLE 56. Years considered for the study
TABLE 57. Exchange rates considered

★調査レポート[世界の骨髄異形成症候群（MDS）治療市場2022年-2028年：治療種類別（化学療法、免疫治療、幹細胞移植、その他）、エンドユーザー別、地域別] (コード：BZW22JY097)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の骨髄異形成症候群（MDS）治療市場2022年-2028年：治療種類別（化学療法、免疫治療、幹細胞移植、その他）、エンドユーザー別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 多形性膠芽腫治療の世界市場2021年-2028年：治療別（放射線治療、免疫治療）、医薬品クラス別、エンドユーザー別、地域別
    GV21SP040 / Grand View Research / 2021年9月15日 / グランドビューリサーチ社は、多形性膠芽腫治療の世界市場規模が2028年までに42億ドルに達し、2021年から2028年までに年平均8.8％成長すると予想しています。本市場調査レポートは、世界の多形性膠芽腫治療市場を調査対象とし調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、治療別（手術、放射線治療、化学治療、標的治療、腫瘍治療フィールド治療、その他）分析、医薬品クラス別（テモゾロミド、ベバシズマブ、ロムスチン、カルムスチンウェファー、その他）分析、エンドユーザー別（病院、クリニック、ASC）分析、地域別分析、競争分析などを掲載しています。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場変動・動向・範囲 ・多形性膠芽腫治療の世界市場規模：治療別（手術、放射線治療、化学治療、標的治療、腫瘍治療フィールド治療、その他）...
  • 世界の紡錘細胞肉腫治療薬市場2022年-2028年：薬物療法別（化学療法、標的療法、免疫療法、その他）、薬物種類別、エンドユーザー別、流通チャネル別、地域別
    BZW22AP282 / Bizwit Research & Consulting / 2022年3月2日 / Bizwit Research社は、世界の紡錘細胞肉腫治療薬市場規模が2021年XX億ドルに達し、2022年から2028年までにXX％成長すると予想しています。本調査レポートは、紡錘細胞肉腫治療薬の世界市場について調査し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、薬物療法別（化学療法、標的療法、免疫療法、その他）分析、薬物種類別（ブランド、ジェネリック）分析、エンドユーザー別（病院、専門クリニック、在宅医療、その他）分析、流通チャネル別（直接入札、病院薬局、小売薬局、オンライン薬局、その他）分析、地域別分析、競争状況、調査プロセスなどを整理しました。 ・エグゼクティブサマリー ・市場定義・範囲 ・市場動向...
  • 世界の小児神経芽細胞腫治療薬市場2022年-2028年：治療法別（化学療法、免疫療法、その他）、流通チャネル別、地域別
    BZW22JN211 / Bizwit Research & Consulting / 2022年5月27日 / Bizwit Research社は、2021年におよそXXであった世界の小児神経芽細胞腫治療薬市場規模が、2022年から2028年の間に6%以上成長すると予測しています。本調査レポートでは、小児神経芽細胞腫治療薬の世界市場について調査し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、治療法別（化学療法、免疫療法、その他）分析、流通チャネル別（病院薬局、小売店薬局）分析、地域別分析、競争分析、調査プロセスなどを掲載しています。本調査レポートでは、United Therapeutics Corporation、APEIRON Biologics...
  • 世界のリンパ浮腫治療市場2021年-2027年：治療種類別（圧迫治療、手術、薬物治療、レーザー治療、その他）、種類別、患部別、年齢層別、投与経路別、エンドユーザー別、流通チャネル別、地域別
    BZW22FB235 / Bizwit Research & Consulting / 2022年1月15日 / Bizwit Research社は、世界のリンパ浮腫治療市場規模が2020年にXXXX億ドル、2021年から2027年までにXXXX％成長すると予想しています。本市場調査資料では、リンパ浮腫治療の世界市場を広く調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、治療種類別（圧迫治療、手術、薬物治療、レーザー治療、その他）分析、種類別（原発性リンパ浮腫、二次性リンパ浮腫）分析、患部別（性器、下肢、上肢、その他）分析、年齢層別（成人、高齢者）分析、地域別分析、競争状況、調査プロセスなど、以下の構成でまとめました。 ・エグゼクティブサマリー ・市場定義・範囲 ・市場動向...
  • 子宮内膜症治療の世界市場2021-2027：薬剤種類別{経口避妊薬、プロゲスチン、NSAID、GnRHアナログ、LNR-IUD、その他}、治療種類別、エンドユーザー別、地域別
    BZW21OC126 / Bizwit Research & Consulting / 2021年9月2日 / Bizwit Research社は子宮内膜症治療の世界市場規模が2020年にXXX億ドルに達し、2021年から2027年までXX％成長すると予想しています。本市場調査レポートでは、世界の子宮内膜症治療市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、薬剤種類別（経口避妊薬、プロゲスチン、NSAID、GnRHアナログ、LNR-IUD）分析、治療種類別（ホルモン治療、疼痛管理）分析、エンドユーザー別（病院薬局、小売薬局、ドラッグストア、Eコマース）分析、地域別分析、競争状況、調査プロセスなどの項目を掲載しています。 ・エグゼクティブサマリー ・市場定義・範囲 ・市場動向...

    • ◆H&Iグローバルリサーチのお客様（例）◆